Safety Advisory 26-01 Overhead Catenary System (OCS) and Pantograph Reliability
Published . Updated .
Due to aggressive automated scraping of FederalRegister.gov and eCFR.gov, programmatic access to these sites is limited to access to our extensive developer APIs. Please visit FederalRegister.gov API documentation or eCFR.gov API documentation to learn more about how to access
Directly affected
- OCS Oculis Holding AG
Named in this report.
Indirectly affected
- XLV Health Care Select Sector SPDR
Health Care Select Sector SPDR holds the health sector that Oculis Holding AG belongs to, so it often moves with news about it.
- NVS Novartis AG+1.3% 17d
Novartis AG is a peer of Oculis Holding AG in pharmaceutical preparations; rivals often move on the same news.
- AZN AstraZeneca+11.1% 30d
AstraZeneca is a peer of Oculis Holding AG in pharmaceutical preparations; rivals often move on the same news.
- NVO Novo Nordisk A/S-7.3% 30d
Novo Nordisk A/S is a peer of Oculis Holding AG in pharmaceutical preparations; rivals often move on the same news.
- GSK Gsk-6.3% 10d
Gsk is a peer of Oculis Holding AG in pharmaceutical preparations; rivals often move on the same news.
- SNY Sanofi
Sanofi is a peer of Oculis Holding AG in pharmaceutical preparations; rivals often move on the same news.
Price reaction, T-5 to T+3
| Ticker | T-5 | T-3 | T-1 | T0 | T+1 | T+2 | T+3 |
|---|---|---|---|---|---|---|---|
| OCSNo price data for this ticker | — | — | — | — | — | — | — |
| XLVNo price data for this ticker | — | — | — | — | — | — | — |
| NVSNo price data for this ticker | — | — | — | — | — | — | — |
| AZNNo price data for this ticker | — | — | — | — | — | — | — |
| NVONo price data for this ticker | — | — | — | — | — | — | — |
| GSKNo price data for this ticker | — | — | — | — | — | — | — |
| SNYNo price data for this ticker | — | — | — | — | — | — | — |
Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.
Market Call
Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.
The Federal Transit Administration (FTA) is issuing Safety Advisory 26-01 to recommend State Safety Oversight Agencies (SSOAs) direct Rail Transit Agencies (RTAs) within their jurisdiction to use their Safety Management System (SMS) to ide…
Source: Federal Register
Congressional trades in the stocks in this story
- Rep. Kevin Hern sold Novartis Ag (NVS), worth $15,001 - $50,000 on 27 Aug 2026. That is 63 days before publication. Filed 25 Sep 2026. View the filing.
- Rep. Kevin Hern sold Novo Nordisk A S (NVO), worth $1,001 - $15,000 on 10 Sep 2026. That is 49 days before publication. Filed 25 Sep 2026. View the filing.
- Rep. Kevin Hern sold Novo Nordisk A S (NVO), worth $1,001 - $15,000 on 31 Aug 2026. That is 59 days before publication. Filed 25 Sep 2026. View the filing.
- Rep. Scott Scott Franklin bought Novo Nordisk A S (NVO), worth $1,001 - $15,000 on 26 Aug 2026. That is 64 days before publication. Filed 17 Sep 2026. View the filing.
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
This story
25 out of 100
“Safety Advisory 26-01 Overhead Catenary System (OCS) and Pantograph Reliability” scores 25 out of 100. The score uses 2 sources.